Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX)

Reproductive Toxicology

Volumn 25, Issue 4, 2008, Pages 433-441

  Longo, Monica ^a   Zanoncelli, Sara ^a   Della Torre, Paola ^a   Rosa, Francesco ^a   Giusti, AnnaMaria ^a   Colombo, Paolo ^a   Brughera, Marco ^a   Mazué, Guy ^a   Olliaro, Piero ^b,c  

^a Nerviano Medical Sciences Srl ^*  (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antimalarial drug; Dihydroartemisinin; Embryotoxicity; FETAX; Red blood cells; Xenopus

Indexed keywords

DIHYDROARTEMISININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; ERYTHROCYTE; FERTILIZATION; FROG; LARVA; NONHUMAN; PREGNANCY; RAT; TERATOGENESIS;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; MICROSCOPY, ELECTRON, TRANSMISSION; XENOPUS LAEVIS;

ANIMALIA; ANURA; RATTUS;

EID: 48949116218     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.02.004     Document Type: Article

References (54)

1. Brabin B. Malaria in pregnancy: current issues. Afr Health 19 (1997) 19-20
2. Desai M., ter Kuile F.O., Nosten F., et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 7 (2007) 93-104
3. Taylor W.R., and White N.J. Antimalarial drug toxicity. Drug Safety 27 1 (2004) 25-61
4. McGready R., Cho T., Keo N.K., et al. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis 33 (2001) 2009-2016
5. Ward S.A., Sevene E.J.P., Hastings I.M., Nosten F., and McGready R. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis 7 (2007) 136-144
6. Qinghaosu Antimalarial Coordinating Research Group. Antimalarial studies on qinghaosu. Chin Med J 92 (1979) 111-167
7. Hien T.T., and White N.J. Qinghaosu. Lancet 341 (1993) 603-608
8. Price R.N. Artemisinin drugs: novel antimalarial agents. Expert Opin Investig Drugs 9 8 (2000) 1815-1827
9. Adjuik M., et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 9402 (2004) 9-1710
10. World Health Organization. Antimalarial drug combination therapy. WHO; 2001. WHO/CDS/RBM/2001.35.
11. World Health Organization Regional Office for Africa. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville; 2004.
12. World Health Organization. Assessment of the safety of artemisinin compounds in pregnancy. Report of two informal consultations convened by WHO in 2002. (RBM and TDR). WHO/CDS/MAL/2003.1094.
13. Clark R.L., White T.E., Clode A., Gaunt I., Winstanley P., and Ward S.A. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B 71 (2004) 380-394
14. White T.E., Clode S., Gaunt I., Ward S., Powell C., and Clark R.L. Developmental toxicity of the antimalarial artesunate in rats and rabbits. Birth Defects Res A 70 (2004) 265
15. White T.E., Bushdid P.B., Ritter S., Laffan S.B., and Clark R.L. Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B 77 (2006) 413-429
16. Longo M., Zanoncelli S., Della Torre P., et al. In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. Reprod Toxicol 22 (2006) 797-810
17. Longo M., Zanoncelli S., Manera D., et al. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reprod Toxicol 21 (2006) 83-93
18. Chen L.J., Wang M.Y., Sun W.K., and Liu M.Z. Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits. Acta Pharmacol Sinica 5 2 (2004) 118-122
19. Clark R.L., Kumemura M., Makori N., et al. Artesunate: developmental toxicity in monkeys. Birth Defects Res A 76 (2006) 329 [Abstract]
20. Deen J.L., von Seidlein L., Pinder M., Walraven G.E., and Greenwood B.M. The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg 95 (2001) 424-428
21. Deen J.L., and von Seidlein L. Antimalarial use during pregnancy and its effect on birthweight. Trans R Soc Trop Med Hyg 96 (2002) 573-574
22. McGready R., Cho T., Cho J.J., et al. Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 92 (1998) 430-433
23. McGready R., Cho T., Samuel, et al. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 95 6 (2001) 651-656
24. McGready R., Brockman A., Cho T., et al. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 94 6 (2000) 689-693
25. McGready R., Cho T., Keo N.K., et al. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis 33 12 (2001) 2009-2016
26. McGready R., and Nosten F. The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy. Ann Trop Med Parasitol 93 Suppl. 1 (1999) S19-S23
27. McGready R., Keo N.K., Villegas L., White N.J., Looareesuwan S., and Francois N. Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg 97 (2003) 592-594
28. McGready R. The use of artemisinin derivatives in pregnancy: the experience on the Thai-Burma border. PREMA-EU Newslett. November (1) (2002)
29. Adam I., Elwasila E., Mohammed Ali D., Elansari E., and Elbashir M.I. Artemether in the treatment of falciparum malaria during pregnancy in Easter Sudan. Trans R Soc Trop Med Hyg 98 (2004) 509-513
30. Adam I., Ali D.M., and Abdalla M.A. Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan. Trans R Soc Trop Med Hyg 100 (2006) 632-635
31. Bantle J.A., Fort D.J., Rayburn J.R., De Yong D.J., and Bush S.J. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens. Drug Chem Toxicol 13 (1990) 267-282
32. Bantle J.A., Burton D.T., Dawson D.A., et al. FETAX interlaboratory validation study: phase II testing. Environ Toxicol Chem 13 (1994) 1629-1637
33. Bantle J.A., Dumont J.N., Finch R., and Linder G. Atlas of abnormalities: a guide for the performance of FETAX (1991), Oklahoma State Publications Department, Stillwater, OK 69 pp.
34. Bantle J.A., Fort D.J., and Dawson D.A. Bridging the gap from short-term teratogenesis assays to human health hazard assessment by understanding common modes of teratogenic action. In: Cowgill U.M., and Williams L.R. (Eds). Aquatic toxicology and hazard assessment (1988) 46-57
35. ASTM. Standard guide for conducting the frog embryo teratogenesis assay, Xenopus (FETAX). E 1439-91. Annual book of ASTM standards. Philadelphia: American Society for Testing and Materials; 1991. p. 1-11.
36. Department of Health and Human Services NIoH, ICCVAM Special Emphasis Panel. Xenopus (FETAX). A proposed screening method for identifying the developmental toxicity potential of chemicals and environmental samples. NC, USA; 2000.
37. Fort D.J., Stower E.L., Farmer D.R., and Lemen J.K. Assessing the predictive validity of Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Teratogen Carcinog Mut 20 (2000) 87-98
38. Vismara C., Bernardini G., Bonfanti P., Colombo A., and Camatini M. The use of in vitro fertilization in the Frog Embryo Teratogenesis Assay in Xenopus (FETAX) and its applications to ecotoxicology. Sci Total Environ Suppl. Pt 1 (1993) 787-790
39. Dawson D.A., and Bantle J.A. Development of a reconstituted water medium and preliminary validation of the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). J Appl Toxicol 7 (1987) 237-244
40. In: Nieuwkoop P.D., and Faber J. (Eds). Normal table of Xenopus laevis (Daudin): a systematical and chronological survey of the developmental stages from the fertilized egg till the end of metamorphosis. 2nd ed. (1975), North-Holland Publishing Company, Amsterdam
41. Baumann R., and Dragon S. Erythropoiesis and red cell function in vertebrate embryos. Eur J Clin Investig 35 (2005) 2-12
42. Kau C.L., and Turpen J.B. Dual contribution of embryonic ventral blood island and dorsal lateral plate mesoderm during ontogeny of hematopoietic cells in Xenopus laevis. J Immunol 131 (1983) 2262-2266
43. Zon L.I. Developmental biology of hematopoiesis. Blood 86 (1995) 2876-2891
44. Jiang J.B., Jacobs G., Liang D.S., and Aikawa M. Qinghaosu-induced changes in the morphology of Plasmodium inui. Am J Trop Med Hy. 34 3 (1985) 424-428
45. Meshnick S.R. Artemisinin antimalarials: mechanisms of action and resistance. Med Trop 58 (1998) 13-17
46. Meshnick S.R. Atemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32 13 (2002) 1655-1660
47. Varadharajan S., Dhanasekaran S., Bonday Z.Q., Rangarajan P.N., and Padmanaban G. Involvement of delta-aminolaevulinate synthase encoded by the parasite gene in de novo haem synthesis by Plasmodium falciparum. Biochem J 367 Pt 2 (2002) 321-327
48. Maeno Y., Toyoshima T., Fujioka H., et al. Morphologic effects of artemisinin in Plasmodium falciparum. Am J Trop Med Hyg 49 4 (1993) 485-491
49. Laffan S.B., James A., Beverly M., et al. Mitochondrial involvement of artesunate toxicity in the rat embryonic erythroblasts. Birth Defects Res A 76 (2006) 329
50. Krungkrai J., Burat D., Kudan S., Krungkrai S., and Prapunwattana P. Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum. Southeast Asian J Trop Med Public Health 30 4 (1999) 636-642
51. Li W., Mo W., Shen D., et al. Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet 1 3 (2005) e36
52. Dellicour S., Hall S., Chandramohan D., and Greenwood B. The safety of artemisinins during pregnancy: a pressing question. Malaria J 6 (2007) 15
53. Brittain T. Molecular aspects of embryonic hemoglobin function. Mol Aspects Med 23 (2002) 293-342
54. World Health Organization (WHO). Guidelines for the treatment of malaria. WHO/HTM/MAL/2006.1108.